Most Read Articles
01 Mar 2016
Combination therapy with ezetimibe/statin improved low-density lipoprotein (LDL) cholesterol levels and cardiovascular outcomes in patients with acute coronary syndrome (ACS), as stated in a 16-week one-centre, prospective, randomised, open-label clinical trial.
13 Aug 2016
Prasugrel is superior than clopidogrel in the treatment of acute coronary syndrome (ACS) and ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) as presented in a study.
01 Mar 2016
Earlier oral β blocker administration is substantially correlated with lower rates of left ventricular (LV) dysfunction and in-hospital mortality in acute coronary syndrome patients, according to a study.
16 Dec 2018
The absence of the classical symptom of chest pain in patients with acute myocardial infarction (AMI) appears to be associated with more complications and higher short- and long-term mortality rates, particularly in younger and healthier patients, according to a study.

sST2 predicts death, hospitalization in chronic HF beyond NT-proBNP, hsTnT

08 Nov 2018

Soluble suppression of tumorigenesis-2 (sST2) is a strong, independent predictor of all-cause and cardiovascular mortality, as well as heart failure (HF) hospitalization in chronic HF, reports a study.

The authors retrieved individual patient data from studies that assessed sST2 for risk prediction in chronic HF, together with N-terminal pro–B-type natriuretic peptide (NT-proBNP) and high-sensitivity troponin T (hs-TnT).

Of the 4,268 patients evaluated (median age 68 years; 75 percent males), 65 percent had ischaemic HF and 87 percent had left ventricular ejection fraction (LVEF) <40 percent. NT-proBNP was 1,360 ng/l (interquartile interval, 513–3,222 ng/l), hs-TnT 18 ng/l (interquartile interval, 9–33 ng/l) and sST2 27 ng/l (interquartile interval, 20–39 ng/l).

All-cause death occurred in 1,319 patients (31 percent), while cardiovascular death occurred in 939 (22 percent), during a median follow-up of 2.4 years. Of the patients, 4,118 (96 percent) had available data, of which 1,029 (24 percent) were hospitalized at least once for worsening HF over 2.2 years.

The best sST2 cutoff for predicting all-cause and cardiovascular death and HF hospitalization was 28 ng/ml, with good performance at Kaplan-Meier analysis (log-ran: 117.6, 61.0 and 88.6, respectively; p<0.001 for all).

A model including age, sex, body mass index, ischaemic aetiology, LVEF, New York Heart Association functional class, glomerular filtration rate, HF medical therapy, NT-proBNP and hs-TnT showed that the risk of all-cause mortality increased by 26 percent, cardiovascular mortality by 25 percent and HF hospitalization by 30 percent per each doubling of sST2.

Additionally, the independent prognostic value of sST2 persisted across most population subgroups.

According to the authors, sSt2 deserves consideration to be part of a multimarker panel together with NT-proBNP and hs-TnT.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Mar 2016
Combination therapy with ezetimibe/statin improved low-density lipoprotein (LDL) cholesterol levels and cardiovascular outcomes in patients with acute coronary syndrome (ACS), as stated in a 16-week one-centre, prospective, randomised, open-label clinical trial.
13 Aug 2016
Prasugrel is superior than clopidogrel in the treatment of acute coronary syndrome (ACS) and ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) as presented in a study.
01 Mar 2016
Earlier oral β blocker administration is substantially correlated with lower rates of left ventricular (LV) dysfunction and in-hospital mortality in acute coronary syndrome patients, according to a study.
16 Dec 2018
The absence of the classical symptom of chest pain in patients with acute myocardial infarction (AMI) appears to be associated with more complications and higher short- and long-term mortality rates, particularly in younger and healthier patients, according to a study.